Artemis Medicare Services to present at EMKAY Confluence 2026 in Mumbai
Artemis Medicare Services Limited confirmed its participation in the EMKAY Confluence 2026 investor conference scheduled for August 13, 2026, in Mumbai. The disclosure, filed under Regulation 30 of SEBI LODR, highlights the company's commitment to transparent communication with institutional investors through physical interaction.

*this image is generated using AI for illustrative purposes only.
Artemis Medicare Services will participate in the EMKAY Confluence 2026 investor conference on August 13, 2026, providing a direct channel for dialogue with institutional investors and equity analysts. The event, titled 'India: Full Throttle Ahead,' serves as an annual forum for market participants to assess corporate strategies and financial outlooks within the Indian healthcare sector.
The disclosure was made on August 10, 2026, pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulatory requirement ensures timely transparency regarding material events that may influence investor sentiment or trading activity. The company has notified both the National Stock Exchange of India Limited and BSE Limited of its scheduled appearance.
Event Details
The conference will be held in Mumbai in a physical format, facilitating face-to-face interactions between company representatives and the investment community. This mode of engagement allows for more detailed discussions compared to virtual presentations, enabling investors to probe deeper into operational metrics and strategic initiatives.
| Date | Event Name | Location | Mode |
|---|---|---|---|
| August 13, 2026 | EMKAY Confluence 2026: 'India: Full Throttle Ahead' | Mumbai | Physical Conference |
Regulatory Compliance
Poonam Makkar, Company Secretary and Compliance Officer of Artemis Medicare Services Limited, signed the disclosure letter. The filing explicitly notes that the schedule is subject to change due to exigencies on the part of analysts, investors, or the company. Such contingencies are standard in investor relations calendars but require immediate communication if alterations occur to maintain regulatory compliance.
Strategic Context
Participation in high-profile investor conferences like EMKAY Confluence signals management's intent to reinforce visibility among domestic and international fund managers. For healthcare providers, these platforms are critical for communicating service expansion plans, patient volume trends, and margin sustainability amidst evolving reimbursement landscapes. The physical nature of the event underscores the importance Artemis places on direct stakeholder engagement during this fiscal period.
Historical Stock Returns for Artemis Medicare Services
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.22% | +7.25% | +17.27% | +40.50% | +32.20% | +825.02% |
What specific strategic initiatives or service expansion plans is Artemis Medicare likely to highlight to justify its growth trajectory at the EMKAY Confluence?
How might the company's commentary on margin sustainability address current concerns regarding evolving reimbursement landscapes in the Indian healthcare sector?
Could Artemis's participation in this high-profile physical conference signal an upcoming capital raising effort or significant M&A activity?


































